Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of High- vs Low-Dose Sirolimus in Patients With Kaposiform Hemangioendothelioma: A Trial Protocol

NCT04775173 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT04775173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04775173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of High- vs Low-Dose Sirolimus in Patients With Kaposiform Hemangioendothelioma: A Trial Protocol
Lead sponsor
West China Hospital
Phase
Phase 2
Overall status
Completed
Start date
February 17, 2021
Completion date
August 10, 2023
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kaposiform hemangioendothelioma